Nima Hassan Rezaeian, PhD

Assistant Attending Physicist

Nima Hassan Rezaeian, PhD

Assistant Attending Physicist
Nima Hassan Rezaeian


PhD, Physics, University of North Texas; MSc and BSc, University of Tehran

I was born and raised in Tehran, Iran. I studied Condensed Matter Physics at the University of Tehran. After finishing my Bachelor of Science with honoree rank, I started my Master of Science in Nuclear Physics at the same university. Subsequently, I traveled to the US and earned a PhD in Atomic Physics from the University of North Texas, where I studied how to precisely measure the size of helium isotopes using atomic techniques.

After graduation, I went on to complete a postdoctoral fellowship and residency at the University of Texas Southwestern Medical Center before joining Memorial Sloan Kettering. My research interests include novel treatment techniques in brachytherapy and automation, motion management and tracking in radiation therapy, and realistic models to study the dose response in stereotactic body radiotherapy.


Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Nima Hassan Rezaeian discloses the following relationships and financial interests:

No disclosures meeting criteria for time period

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures